alexa

GET THE APP

Enhance the FDA's Postmarketing Drug Surveillance System of Adverse Effects through the Electronic Healthcare Data | OMICS International| Abstract
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Epidemiol 2012, Vol 2(2): e104
  • DOI: 10.4172/2161-1165.1000e104

Enhance the FDA's Postmarketing Drug Surveillance System of Adverse Effects through the Electronic Healthcare Data

Xianglin L Du*
Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Texas, USA
*Corresponding Author : Xianglin L Du, Division of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, 1200 Herman Pressler Drive, RAS-E631, Houston, TX 77030, USA, Tel: 713-500-9956, Fax: 713-500-9264, Email: [email protected]

Received Date: Oct 04, 2012 / Accepted Date: Oct 07, 2012 / Published Date: Oct 10, 2012

Abstract

Du XL (2012) Enhance the FDA’s Postmarketing Drug Surveillance System of Adverse Effects through the Electronic Healthcare Data. Epidemiol 2:e104.

Keywords: Postmarketing drug surveillance; Adverse effects; Drug therapy; Electronic healthcare data

Citation: © 2012 Du XL. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Doi: 10.4172/2161-1165.1000e104

Top